*** Proof of Product ***
Exploring the Essential Features of “Alicia Elam – Asthma Interventions”
Speaker:Alicia Elam, PharmD
Duration:1 Hour 32 Minutes
Format:Audio and Video
Copyright:May 11, 2023
Media Type:Digital Seminar
Description
Everything you have known and practiced in the management of asthma for the past 50 years is no longer relevant! The Global Initiative for Asthma (GINA) Guidelines have totally revamped the approach to asthma management and as a primary care provider, this is information you absolutely need to know. In this session, you will learn the current asthma treatment strategies with the goal of preventing deaths and exacerbations, with new guidelines for prescribing albuterol as a rescue inhaler. You will walk away with a new understanding of the best way to manage asthma in 2023 and beyond!
Speaker
Alicia Elam, PharmD, is a pharmacist and tenured associate professor of pharmacology at Augusta Universityβs College of Allied Health Sciences. Not only does she oversee admissions for the physician assistant program and relish mentoring students interested in advanced degrees in medicine, pharmacy, and allied health services, but she also directs pharmacology courses for PA students and consults for various academic programs, including nursing. Dr. Elam is responsible for keen insights and guideline updates for opioid prescribing. With over 28 years of pharmacology experience, her expertise is further underscored by her services as a Lieutenant and Medical Services Corps Pharmacy Officer in the US Navy.
Speaker Disclosures:
Financial: Alicia Elam has an employment relationship with Augusta University. She receives a speaking honorarium from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Alicia Elam is a member of the Georgia Pharmacist Association, the Physician Assistant Education Association, National Pharmaceutical Association, and the Georgia Association of Physician Assistants.
Objectives
- Determine goals of asthma therapy as it relates to the GINA Strategy.
- Analyze why SABAs have been demoted as a rescue inhaler in the management of asthma.
- Determine the LABA-ICS of choice according to the GINA Strategy.
- Evaluate with monotherapy asthma inhaler class is contraindicated in the management of asthma.
Outline
What is GINA?
Discuss Anti-Asthmatic Drugs and how they are employed in the GINA strategy
- SABAs
- LABAs + ICS
- LAAC
- ICS
- LTR
Discuss how the GINA Strategy has changed the use of albuterol in the management of asthma
Compare previous asthma treatment guidelines to the current GINA strategy
Discuss the US Boxed Warning associated with LABAs in the management of asthma
Discuss alternative asthma treatments/other controller options employed in the GINA Strategy
Target Audience
- Nurses
- Nurse Practitioners
- Physician Assistants
- Physicians
- Respiratory Therapists
Please see the full list of alternative group-buy courses available here: https://lunacourse.com/shop/